We thank Dr Bhagirath and co-authors for their knowledgeable comments on our study [1]. We agree that cardiac magnetic resonance imaging (CMR) has many applications that are relevant to cardiac resynchronisation therapy (CRT) implantation guidance. Indeed, as pointed out by Bhagirath and co-authors, a study from the London group [2] proposed coronary venous anatomy imaging by CMR. The same group also demonstrated the comprehensive use of computed tomography in selecting the optimal coronary vein for left ventricular lead placement by targeting regions of late mechanical activation and avoiding scarring [3].
The scope of our study was not to prove the superiority of one technique to the other. Instead, our study focused on sharing our clinical experience with coronary venous anatomy visualisation by computed tomography and comparing this with fluoroscopic angiography, as the latter technique is traditionally used in coronary venous anatomy delineation.
Many cardiac imaging modalities have been studied for left ventricular lead guidance and CRT response prediction with each having its own strengths and limitations. The utility of each technique may depend on its purpose. Both CMR and computed tomography indeed have the potential to image the coronary veins. CMR has the advantage of avoiding ionising radiation and is more commonly used in clinical practice for focal scar evaluation using delayed enhancement and for functional analyses of the left ventricle using cine imaging. However, CMR has lower spatial resolution compared with computed tomography, which is a factor particularly relevant for the visualisation of small and delicate blood vessels [4].
Furthermore, a substantial number of CRT candidates already have existing pacing systems, and thus a contraindication for CMR. On the other hand, coronary venous computed tomography using contrast media may be contraindicated in patients with severe kidney impairment.
The future of image-guided CRT may not be a single imaging technique, but an integration of multiple modalities combining the strengths of multiple techniques. Key components in this process (and relevant for left ventricular lead guidance) include coronary venous anatomy, electrical or mechanical activation, and scar or viability delineation (Fig. 1). Each aspect may be assessed through different imaging techniques complementing each other to reach a common goal.
Fig. 1 [Images not available. See PDF.]
Schematic overview representing the key components relevant for left ventricular lead placement including the imaging techniques that may evaluate these aspects (CMR cardiac magnetic resonance imaging, CT computed tomography, ECG electrocardiography, SPECT single-photon emission tomography, MPS myocardial perfusion scintigraphy, Q-LV intrinsic local electrical delay at the left ventricular lead)
References
1. Bhagirath, P; Zweerink, A; Allaart, C; Götte, M. Imaging for cardiac resynchronisation therapy requires cardiac magnetic resonance. Neth Heart J; 2018; 26,
2. Shetty, AK; Duckett, SG; Ginks, MR et al. Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling. Eur Heart J Cardiovasc Imaging; 2013; 14,
3. Behar, JM; Rajani, R; Pourmorteza, A et al. Comprehensive use of cardiac computed tomography to guide left ventricular lead placement in cardiac resynchronization therapy. Heart Rhythm; 2017; 14,
4. Chen, YA; Nguyen, ET; Dennie, C et al. Computed tomography and magnetic resonance imaging of the coronary sinus: anatomic variants and congenital anomalies. Insights Imaging; 2014; 5,
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
The same group also demonstrated the comprehensive use of computed tomography in selecting the optimal coronary vein for left ventricular lead placement by targeting regions of late mechanical activation and avoiding scarring [3]. See PDF.] Schematic overview representing the key components relevant for left ventricular lead placement including the imaging techniques that may evaluate these aspects (CMR cardiac magnetic resonance imaging, CT computed tomography, ECG electrocardiography, SPECT single-photon emission tomography, MPS myocardial perfusion scintigraphy, Q-LV intrinsic local electrical delay at the left ventricular lead) References 1. Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Maastricht University Medical Center (MUMC+), Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382); Maastricht University Medical Center (MUMC+), Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382)
2 Maastricht University Medical Center (MUMC+), Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382)
3 Maastricht University Medical Center (MUMC+), Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382)
4 Maastricht University Medical Center (MUMC+), Department of Radiology & Nuclear Medicine, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382)
5 Maastricht University Medical Center (MUMC+), Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382); Radboud University Medical Center, Department of Cardiology, Nijmegen, The Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382)